Area of research
Cancer Research · Oncology
Research interest
Research interests include Breast Cancer Treatment Studies, Global Cancer Incidence and Screening, Breast Lesions and Carcinomas, and Cancer Genomics and Diagnostics.
Integrating genetic polymorphisms and clinical data to develop predictive models for skin toxicity in breast cancer radiation therapy
The Lancet Breast Cancer Commission
Risk-prediction models in postmenopausal patients with symptoms of suspected ovarian cancer in the UK (ROCkeTS): a multicentre, prospective diagnostic accuracy study
Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer
Predictors of long-term adverse quality of life following breast cancer treatment – Insights from the REQUITE cohort study
(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer
Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
Learning to distinguish progressive and non-progressive ductal carcinoma in situ
Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study
Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
Variability in grading of ductal carcinoma <i>in situ</i> among an international group of pathologists
A data science approach for early-stage prediction of Patient's susceptibility to acute side effects of advanced radiotherapy
External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer